EXEL - Exelixis, Inc. - SEC Form 4 Insider Trading Screener

Services - Engineering, Accounting, Research, Management Services - Commercial Physical & Biological Research - EXEL (939767)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
43 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P1+6+7+49+148
S31-0-1+0+90

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2018-01-08
EXELGarber Alan MDirS - Sale+OE$30.30-15,00061,329-20%-$454,515
DM
2017-09-27
EXELHessekiel JeffreyEVP, GCS - Sale+OE$24.28-27,302268,260-9%-$663,018
DM
2017-09-26
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.79-100,000197,191-34%-$2,378,667
2017-09-22
EXELPapadopoulos SteliosDirS - Sale$25.40-10,0001,034,314-1%-$254,000
M
2017-09-18
EXELPapadopoulos SteliosDirS - Sale$27.68-200,0001,044,314-16%-$5,535,387
2017-09-14
EXELHaley Patrick J.SVP, CommercialS - Sale$27.21-60,64075,046-45%-$1,650,014
M
2017-09-12
EXELWillsey LanceDirS - Sale$26.88-100,000468,273-18%-$2,688,000
D
2017-09-12
EXELSenner Christopher J.EVP, CFOS - Sale+OE$26.79-100,000104,798-49%-$2,679,000
DM
2017-09-12
EXELMorrissey MichaelPres, CEOS - Sale+OE$26.90-300,000249,718-55%-$8,071,000
2017-05-30
EXELHaley Patrick J.SVP, CommercialS - Sale$18.46-5,000135,686-4%-$92,300
D
2017-05-15
EXELFeldbaum Carl BDirS - Sale+OE$21.58-32,98834,733-49%-$711,831
DM
2017-05-08
EXELMorrissey MichaelPres, CEOS - Sale+OE$21.87-211,300249,716-46%-$4,622,159-2
DM
2017-05-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.24-259,149249,668-51%-$5,762,838-10
D
2017-05-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$23.01-89,910184,690-33%-$2,068,519-2-3
D
2017-04-03
EXELMarchesi Vincent TDirS - Sale+OE$21.30-10,000120,070-8%-$213,000-4-5+6
D
2017-03-31
EXELWyszomierski Jack LDirS - Sale+OE$21.57-5,15072,960-7%-$111,086-2-6+7
2017-03-27
EXELHessekiel JeffreyEVP, GCS - Sale$21.02-6,884267,946-3%-$144,702-10+3
D
2017-03-22
EXELHessekiel JeffreyEVP, GCS - Sale+OE$20.54-23,787274,830-8%-$488,585+2+1+2
D
2017-03-20
EXELFeldbaum Carl BDirS - Sale+OE$21.77-10,00048,721-17%-$217,7000+4+3
D
2017-03-20
EXELPapadopoulos SteliosDirS - Sale+OE$21.66-10,0001,238,471-1%-$216,6000+4+3
D
2017-03-15
EXELWillsey LanceDirS - Sale+OE$22.86-10,000568,273-2%-$228,6000-8-3
D
2017-03-15
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$22.53-50,007172,027-23%-$1,126,6580-8-3
2017-03-13
EXELCohen CharlesDirS - Sale$21.82-10,000238,180-4%-$218,200+5+1-4
D
2017-03-10
EXELMarchesi Vincent TDirS - Sale+OE$21.98-40,000120,070-25%-$879,200+1+1-5
D
2017-03-03
EXELHessekiel JeffreyEVP, GCS - Sale+OE$23.04-100,000246,617-29%-$2,303,678-2-2-4
DM
2017-03-03
EXELMorrissey MichaelPres, CEOS - Sale+OE$22.72-200,000249,523-44%-$4,544,000-2-2-4
2017-03-03
EXELHaley Patrick J.SVP, CommercialS - Sale$23.04-2,500140,400-2%-$57,600-2-2-4
2017-03-03
EXELSenner Christopher J.EVP, CFOS - Sale$22.80-11,000102,181-10%-$250,800-2-5-6
D
2017-03-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$22.19-45,00089,728-33%-$998,550-2-5-6
DM
2017-03-01
EXELPoste GeorgeDirS - Sale+OE$22.53-76,25077,555-50%-$1,718,185-2-5-6
D
2017-02-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$18.65-70,00089,680-44%-$1,305,500-1+12+13
D
2017-01-03
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$14.65-70,00089,624-44%-$1,025,636+2+21+34
D
2016-12-16
EXELFeldbaum Carl BDirS - Sale+OE$17.03-25,00048,721-34%-$425,750-3-11+7
D
2016-12-09
EXELGarber Alan MDirS - Sale+OE$16.90-7,83261,329-11%-$132,361-2-1+12
DM
2016-12-05
EXELScangos George ADirS - Sale+OE$17.81-204,8941,487,243-12%-$3,649,178+2-2-7
D
2016-12-01
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$16.66-70,00089,624-44%-$1,166,200+3-3-16
D
2016-12-01
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$16.73-22,000171,859-11%-$368,060+3-3-16
D
2016-11-09
EXELMorrissey MichaelPres, CEOS - Sale+OE$15.00-200,000251,329-44%-$3,000,000-1+1-4
D
2016-11-09
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$15.00-22,000171,859-11%-$330,000-1+1-4
D
2016-11-09
EXELLamb PeterEVP, Scientific Strategy, CSOS - Sale+OE$13.15-70,00089,624-44%-$920,500-1+1-4
D
2016-08-31
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$10.98-131,155150,247-47%-$1,440,082+5+4+10+99
D
2016-08-04
EXELSchwab GiselaPres Prod Dev, Med Aff, CMOS - Sale+OE$11.00-42,338145,822-23%-$465,718-2-5+3+82
M
2016-05-09
EXELWillsey LanceDirP - Purchase$4.96+60,000568,273+12%+$297,900+6+7+49+148

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top